Author

Alona Zer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2027

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer.

The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer (NSCLC) were published in August 2025 and were adapted in November 2025 according to previously established standard methodology...

H. Hayashi, A. Zer, H. Kenmotsu et al. · ESMO Open · 0 citations

Open access Jul 2026

Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort

In this multinational real-world cohort, outcomes with first-line chemo-immunotherapy were consistent with CASPIAN trial and the addition of cRT or sRT appeared feasible, safe, and associated with clinically meaningful survival improvements.

U. Janžič, W. Shalata, M. Unk et al. · Frontiers in Oncology · 0 citations